Organization | Wrightington, Wigan and Leigh NHS Foundation Trust

Wrightington, Wigan and Leigh NHS Foundation Trust Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Wigan United Kingdom (2001)

Organization Overview

First Clinical Trial

2010

NCT00973908

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Wrightington Hospital, Wigan UK | Wrightington, Wigan and Leigh NHS Foundation Trust

Active Ingredients

Drugs in Phase 3 Trials (9)

bifidobacterium breve (1 trial)

bifidobacterium infantis (1 trial)

bifidobacterium longum (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

lactobacillus delbrueckii (1 trial)

lactobacillus plantarum (1 trial)

streptococcus salivarius (1 trial)

vsl #3 (1 trial)

Drugs in Phase 2 Trials (1)

cannabidiol (Epidiolex) (1 trial)

Drugs in Other Trials (2)

leukocytes (1 trial)

platelet rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Diarrhea (Phase 3)

Ulcer (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 3
# of Trial APIs: 12